Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2)

Journal of Human Virology

Volumn 2, Issue 1, 1999, Pages 19-32

  Burysek, Ladislav ^a   Yeow, Wen Shuz ^a   Pitha, Paula M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

IRF 1; IRF 3; KSHV; NDV; NF B; P300; Pull down assay; Transcription coactivator; VIRF 2

Indexed keywords

INTERFERON REGULATORY FACTOR 2;

ARTICLE; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; HUMAN HERPESVIRUS 8; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CLONING, MOLECULAR; DNA; DNA, VIRAL; DNA-BINDING PROTEINS; E1A-ASSOCIATED P300 PROTEIN; GENES, REPORTER; HERPESVIRUS 8, HUMAN; HIV ENVELOPE PROTEIN GP120; HIV LONG TERMINAL REPEAT; HUMANS; INTERFERON REGULATORY FACTOR-2; INTERFERON-BETA; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NUCLEAR PROTEINS; OPEN READING FRAMES; PLASMIDS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033508091     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1997;70:549-558.
2. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-656.
3. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984;310:207-211.
4. Albrecht J-C, Nicholas J, Biller D, et al. Primary structure of the herpesvirus saimiri genome. J Virol 1992;66:5047-5058.
5. Russo JJ, Bohenzky RA, Chien M-C, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996;93:14862-14867.
6. Cheng EH-Y, Nicholas J, Bellows D, et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 1997;94:690-694.
7. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature 1996;382:410.
8. Nicholas J, Ruvolo V, Zong J, et al. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J Virol 1997;71:1963-1974.
9. Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996;274:1739-1744.
10. Arvanitakis L, Geras-Raaka E, Varma A, et al. Human herpesvirus (KSHV) encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997;385:347-350.
11. Nguyen H, Hiscott J, Pitha PM. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev 1997;8:293-312.
12. Harada H, Fujita T, Miyamoto M, et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989;58:729-739.
13. Matsuyama T, Kimura T, Kitagawa M, et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993;75:83-97.
14. Reis LF, Ruffner H, Stark G, et al. Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J 1994;13:4798-4806.
15. Ruffner H, Reis LF, Naf D, et al. Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc Natl Acad Sci U S A 1993;90:11503-11507.
16. Levy D, Darnell JEJ. Interferon-dependent transcriptional activation: signal transduction without second messenger involvement? New Biol 1990;2:923-928.
17. Bluyssen HA, Muzaffar R, Vlieststra RJ, et al. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci U S A 1995;92: 5645-5649.
18. Bluyssen HAR, Durbin JE, Levy DE. ISGF3 gamma p48, a specificity switch for IFN activated transcriptional factors. Cytokine Growth Fact Rev 1996;7:11-17.
19. Harada H, Matsumoto M, Sato M, et al. Regulation of IFN-α/β genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-α/β. Genes Cells 1996;1:995-1005.
20. Kimura T, Kadokawa Y, Harada H, et al. Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type III interferon responses, as revealed by gene targeting studies. Genes Cells 1996;1:115-124.
21. Driggers PH, Ennist DL, Gleason SL, et al. An interferon T-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1990;87:3743-3747.
22. Bovolenta C, Driggers PH, Marks MS, et al. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci U S A 1994;91:5046-5050.
23. Weisz A, Marx P, Sharf R, et al. Human interferon consensus sequence binding protein a negative regulator of enhancer elements to interferon-inducible genes. J Biol Chem 1992;267:25589-25596.
24. Holtschke T, Lohler J, Kanno Y, et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996;87:307-317.
25. Nagulapalli S, Atchison ML. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol Cell Biol 1998;18:4639-4650.
26. Brass AL, Kehrli E, Eisenbeis CF, et al. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is import for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev 1996;10:2335-2347.
27. Mittrucker H-W, Matasuyama T, Grossman A, et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997;275:540-543.
28. Au W-C, Moore PA, Lowther W, et al. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci U S A 1995;92:11657-11661.
29. Lin R, Heylbroeck C, Pitha PM, et al. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 1998; 18:2986-2996.
30. Yoneyama M, Suhara W, Fukuhara Y, et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 1998;17:1087-1095.
31. Sato M, Tanaka N, Hata N, et al. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 1998;425:112-116.
32. Schafer SL, Lin R, Moore PA, et al. Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem 1998;273:2714-2720.
33. Juang Y, Lowther W, Kellum M, et al. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci U S A 1998;95:9837-9842.
34. Wathelet MG, Lin CH, Parekh BS, et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1998;1:507-518.
35. Au W-C, Moore PA, LaFleur DW, et al. Characterization of interferon regulatory factor-7, and its potential role in the transcriptional activation of interferon A genes. J Biol Chem 1998;273:29210-7.
36. Zhang L, Pagano JS. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Biol Cell 1998;17:5748-5757.
37. Nonkwelco C, Ruf IK, Sample J. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element. J Virol 1997;71:354-361.
38. Tanaka N, Ishihara M, Kitagawa M, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994;77:829-839.
39. Kirchhoff S, Schaper F, Hauser H. Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res 1993;21:2881-2889.
40. Harada H, Kitagawa M, Tanaka N, et al. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993;259:971-974.
41. Tanaka N, Ishihara M, Lamphier MS, et al. Cooperation of the tumour suppression IRF-1 and p53 in response to DNA damage. Nature 1996;382:555-568.
42. Willman CL, Sever CE, Pallavicini MG, et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemia myelodysplasia. Science 1993;259: 968-971.
43. Boultwood J, Fidler C, Lewis S, et al. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q-chromosome in some patients with the 5q-syndrome. Blood 1993;82:2611-2616.
44. Gao SJ, Boshoff C, Jayachandra S, et al. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997;85:1979-1985.
45. Li M, Lee H, Guo J, et al. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 1998; 72:5433-5440.
46. Zimring JC, Goodboum S, Offermann MK. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 1998;72:701-707.
47. Pitha PM, Burysek L, Schafer S. Critical role of Kaposi sarcoma virus (HHV8)-encoded IRFs in virus replication and pathogenicity. J Interferon Cytokine Res 1997;17 (Suppl 2):S37.
48. Mosca JD, Bednarik DP, Raj NBK, et al. Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. Proc Natl Acad Sci U S A 1987;84:7408-7412.
49. Raj NBK, Au W-C, Pitha PM. Identification of a novel virus-responsive sequence in the promoter of murine interferon-α genes. J Biol Chem 1991;266:11360-11365.
50. Lin R, Gewert D, Hiscott J. Differential transcriptional activation in vitro by NF-kappa B/Rel proteins. J Biol Chem 1995;270:3123-3131.
51. Raj NBK, Israeli R, Kellum M, et al. Upstream regulatory elements of murine α4 gene confer inducibility and cell type-restricted expression. J Biol Chem 1989;264:11149-11157.
52. Bednarik DP, Cook JA, Pitha PM. Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. EMBO J 1990;9:1157-1164.
53. Huang X. On global sequence alignment. Comput Appl Biosci 1994;10:227-235.
54. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
55. Burysek L, Tvrdik P, Houstek J. Expression of interleukin-1 alpha and interleukin-1 receptor type 1 genes in murine brown adipose tissue. FEBS Lett 1993;334:229-232.
56. Neipel F, Albrecht JC, Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenecity? J Virol 1997;71:4187-4192.
57. Sarid R, Flore O, Bohenzky RA, et al. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 1998;72:1005-1012.
58. Ghosh S, May MJ, Kopp EB. NF-kappa B and rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
59. Gerritsen ME, Williams AJ, Neish AS, et al. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 1997;94:2927-2932.
60. Perkins ND, Felzien LK, Betts JC, et al. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 1997;275:523-527.
61. Weaver BK, Kumar KP, Reich NC. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 1998;18:1359-1368.
62. Nelson N, Marks MS, Driggers PH, et al. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol 1993;13:588-599.
63. Scharton-Kersten T, Contursi C, Masumi A, et al. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med 1997;186:1523-1534.
64. Hottiger MO, Felzien LK, Nabel GJ. Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. EMBO J 1998;17:3124-3134.